← Leaderboards
Peter F Mento
Angion Biomedica Corporation
$1,031,827
Attributed
$1,031,827
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,031,827 · 7
By mechanism
R43$1,031,827 · 7
Top collaborators
No co-investigators on record.
Most similar at Angion Biomedica Corporation
Same institution · by research overlap
- Weizhong Cai$17,018,171
- Prakash Narayan$20,015,268
- Latha Paka$8,163,089
- David E Smith$8,398,075
- Bert J. W. M. Oehlen$7,885,442
Others in their field
Top investigators on “Hepatocyte Growth Factor”
- Weizhong Cai · Angion Biomedica Corporation$16,408,566
- Shelly Chi-Loo Lu · Cedars-Sinai Medical Center$14,795,908
- Prakash Narayan · Angion Biomedica Corporation$13,752,713
- Michael Olivier · Medical College Of Wisconsin$10,339,877
- Satdarshan Singh Monga · University Of Hawaii At Manoa$9,838,392
- George K Michalopoulos · University Of Pittsburgh At Pittsburgh$9,578,222
Research focus
Hepatocyte Growth FactorAngiogenesisLaboratory RatTechnology /Technique DevelopmentGene TargetingGene TherapyTransfection /Expression VectorLaboratory MouseAdenoviridaePlasmidsApoptosisDrug Design /Synthesis /ProductionBiomimeticsHypoxiaDrug Screening /EvaluationMyocardial Ischemia /HypoxiaBiotherapeutic AgentGenetic Promoter ElementGenetic TransductionComputer SimulationCombinatorial ChemistryChemopreventionFibrosisCell Proliferation
Grant awards (8)
Hepatocyte Growth Factor Mimetic for Liver Fibrosis$190,321
R43 · FY2003 · DK
Anti-angiogenic &anti-tumor drug for human glioma$250,000
R43 · FY2002 · CA
Renal Injury Prevention by SF/HGF-like Small Molecules$106,822
R43 · FY2002 · DK
ADENOVIRUS SF TRANSDUCTION FOR ANGIOGENIC GENE THERAPY$68,000
R43 · FY2001 · HL
PROMOTION OF WOUND HEALING BY SF/HGF GENE THERAPY$118,096
R43 · FY2000 · GM
LENTIVIRAL GENE THERAPY VECTORS FOR STROKE$117,834
R43 · FY2000 · AA
BONE REGENERATION BY SF/HGF GENE ACTIVATED MATRIX$115,754
R43 · FY2000 · AA
ADENOVIRUS SF TRANSDUCTION FOR ANGIOGENIC GENE THERAPY$65,000
R43 · FY2000 · HL